Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpharma-iq.com
Categories RSS Feed
Get the latest updates from Categories RSS Feed directly as they happen.
Follow now 14 followers
Latest posts
Last updated over 3 years ago
New uses for old drugs: the benefits of reformulation
over 3 years ago
Pharmanovia’s CEO tells Pharma IQ explains how redeveloping existing drugs can benefit...
Improving the success rate of clinical trials
almost 4 years ago
Pharma IQ takes a look at the benefits and challenges of decentralized...
Ukraine's clinical trials still recruiting despite ongoing war
almost 4 years ago
Clinical research in Ukraine is showing signs of recovery more than seven...
Tackling infectious disease with innovative R&D approaches
almost 4 years ago
This guest blog explores the lessons learned from Covid-19 to develop new...
How Sanofi is using AI to accelerate time to market for new drugs
about 4 years ago
Learn more about how AI can accelerate the drug discovery process
Pharma prepares to fight global monkeypox outbreak
about 4 years ago
Pharma companies react to the world’s latest viral outbreak
The benefits of drug reformulation
about 4 years ago
Pharma IQ finds out about the advantages of drug reformulation to develop...
New nanochannels could make next-gen drug discovery more efficient
about 4 years ago
Researchers develop new technique to study biomolecules on the nanoscale
How AI is making drug discovery safer and faster
about 4 years ago
We find out how Sanofi is using AI to predict the toxicity...
Reducing the drug discovery life cycle with AI
about 4 years ago
We find out how Recursion Pharmaceuticals is reducing the drug discovery life...
How to use automation to accelerate drug discovery and delivery
about 4 years ago
Find out how leading biopharma companies are using lab automation for drug...
CRISPR therapy could offer one-time cure for sickle cell disease
about 4 years ago
CRISPR therapy shows promise as a cure for severe sickle cell disease